United Services Automobile Association Enanta Pharmaceuticals Inc Transaction History

United Services Automobile Association

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 13, 2019	SELL	$60.08 - $88.17 $3.1 Million - $4.55 Million	-51,641 Closed	0 $0
Q2 2019 Aug 16, 2019	SELL	$81.3 - $97.35 $179,185 - $214,559	-2,204 Reduced 4.09%	51,641 $4.36 Million
Q1 2019 May 13, 2019	SELL	$69.08 - $105.66 $128,488 - $196,527	-1,860 Reduced 3.34%	53,845 $5.14 Million
Q4 2018 Feb 13, 2019	BUY	$65.41 - $84.65 $876,886 - $1.13 Million	13,406 Added 31.69%	55,705 $3.95 Million
Q3 2018 Nov 13, 2018	BUY	$85.46 - $126.37 $428,154 - $633,113	5,010 Added 13.44%	42,299 $3.62 Million
Q2 2018 Sep 27, 2018	BUY	$81.85 - $120.51 $1.01 Million - $1.48 Million	12,309 Added 49.28%	37,289 $4.32 Million
Q2 2018 Aug 10, 2018	SELL	$81.85 - $120.51 $955,516 - $1.41 Million	-11,674 Reduced 31.85%	24,980 $488,000
Q1 2018 May 14, 2018	BUY	$57.91 - $92.15 $127,865 - $203,467	2,208 Added 6.41%	36,654 $2.97 Million
Q4 2017 Feb 14, 2018	BUY	$45.65 - $59.37 $29,489 - $38,353	646 Added 1.91%	34,446 $2.02 Million
Q3 2017 Nov 14, 2017	BUY	$37.91 - $46.8 $1.28 Million - $1.58 Million	33,800	33,800 $1.58 Million

108

19.7M

9.7K

12.4K

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $166M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

Get notified when there are updates to the investment portfolio of United Services Automobile Association, based on Form 13F filings with the SEC.

Stay updated on United Services Automobile Association with notifications on news.